It’s getting personal: CAR T-cell therapies in multiple myeloma

Video recording by the congress organisers of the Janssen Symposium from the EHA2021 Virtual Congress that took place on 10 June.

Learning objective:

After participating in this webinar, viewers should be able to:

• Discuss the latest evidence supporting the use of CAR T-cell therapies in multiple myeloma
• Evaluate the potential role of CAR T-cell therapies in the management of patients with multiple myeloma  

Scientific Committee:

• Jesús San Miguel (Spain)
• Mohamad Mohty (France)

Faculty:

• Michel Delforge (Belgium)
• Saad Usmani (USA)